SMS Pharmaceuticals, 532815, SMSPHARMA Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,640.99
31.31
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,865.61
0.14%
3.62

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.50
6.81
14.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.53
2.79
20.58

PAT CAGR (%)

10 Years
5 Years
3 Years

4.93
2.03
158.99

P:E (Median)

8 Years
5 Years
3 Years

19.40
28.15
32.56

P:BV (Average)

8 Years
5 Years
3 Years

2.36
2.73
2.93

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.34
15.31
18.46

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 242.43 196.75 23.22% 196.05 164.45 19.22% 248.20 245.80 0.98% 173.35 161.48 7.35%
Expenses 194.05 164.89 17.68% 157.19 130.99 20.00% 206.85 212.31 -2.57% 140.05 132.60 5.62%
EBITDA 48.38 31.86 51.85% 38.86 33.47 16.10% 41.35 33.49 23.47% 33.30 28.88 15.30%
EBIDTM 19.96% 16.19% 19.82% 20.35% 16.66% 13.62% 19.21% 17.88%
Other Income 1.43 1.31 9.16% 0.59 1.37 -56.93% 1.42 1.65 -13.94% 2.13 1.49 42.95%
Interest 5.74 4.61 24.51% 5.84 4.67 25.05% 5.06 5.61 -9.80% 4.20 5.95 -29.41%
Depreciation 10.02 8.62 16.24% 9.75 8.38 16.35% 8.64 7.92 9.09% 8.70 8.01 8.61%
PBT 34.06 19.94 70.81% 23.86 21.78 9.55% 29.06 21.61 34.47% 22.53 16.41 37.29%
Tax 8.91 5.68 56.87% 5.65 5.46 3.48% 8.44 5.69 48.33% 5.36 4.24 26.42%
PAT 25.14 14.26 76.30% 18.21 16.33 11.51% 20.62 15.92 29.52% 17.17 12.17 41.08%
PATM 10.37% 7.25% 9.29% 9.93% 8.31% 6.48% 9.91% 7.54%
EPS 2.68 1.52 76.32% 1.94 1.74 11.49% 2.20 1.70 29.41% 1.83 1.30 40.77%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 242.43 196.75 23.22% 196.05 164.45 19.22% 248.20 245.80 0.98% 173.35 161.48 7.35%
Expenses 194.06 165.28 17.41% 156.68 130.94 19.66% 207.39 212.18 -2.26% 140.14 132.48 5.78%
EBITDA 48.37 31.47 53.70% 39.37 33.51 17.49% 40.81 33.62 21.39% 33.21 29.00 14.52%
EBIDTM 19.95% 15.99% 20.08% 20.38% 16.44% 13.68% 19.16% 17.96%
Other Income 1.43 1.31 9.16% 0.59 1.37 -56.93% 1.42 1.65 -13.94% 2.13 1.49 42.95%
Interest 5.74 4.61 24.51% 5.84 4.67 25.05% 5.06 5.61 -9.80% 4.20 5.95 -29.41%
Depreciation 10.02 8.62 16.24% 9.75 8.38 16.35% 8.64 7.92 9.09% 8.70 8.01 8.61%
PBT 34.04 19.54 74.21% 24.37 21.83 11.64% 28.52 21.74 31.19% 22.44 16.53 35.75%
Tax 8.91 5.68 56.87% 5.65 5.46 3.48% 8.44 5.69 48.33% 5.36 4.24 26.42%
PAT 25.13 13.86 81.31% 18.71 16.37 14.29% 20.08 16.05 25.11% 17.08 12.29 38.97%
PATM 10.37% 7.05% 9.55% 9.96% 8.09% 6.53% 9.85% 7.61%
EPS 2.70 1.67 61.68% 2.31 1.95 18.46% 2.29 2.04 12.25% 2.15 1.36 58.09%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 860.03 782.75 709.26 522.05 519.87 563.18 411.95 464.91 464.93 445.49 611.53 Net Sales Growth 11.91% 10.36% 35.86% 0.42% -7.69% 36.71% -11.39% 0.00% 4.36% -27.15% Cost Of Goods Sold 484.22 436.09 424.04 335.60 275.30 340.00 246.36 292.71 289.90 295.85 385.15 Gross Profit 375.81 346.66 285.22 186.44 244.58 223.18 165.59 172.20 175.03 149.64 226.38 GP Margin 43.70% 44.29% 40.21% 35.71% 47.05% 39.63% 40.20% 37.04% 37.65% 33.59% 37.02% Total Expenditure 698.14 642.77 592.28 467.32 405.10 442.04 331.92 374.77 371.59 370.35 522.32 Power & Fuel Cost - 56.76 47.12 35.97 32.58 23.31 18.99 21.75 22.57 18.23 33.81 % Of Sales - 7.25% 6.64% 6.89% 6.27% 4.14% 4.61% 4.68% 4.85% 4.09% 5.53% Employee Cost - 69.72 56.78 50.08 51.02 41.17 39.35 35.59 32.80 26.92 38.11 % Of Sales - 8.91% 8.01% 9.59% 9.81% 7.31% 9.55% 7.66% 7.05% 6.04% 6.23% Manufacturing Exp. - 42.85 37.87 28.08 25.80 16.28 14.89 13.29 12.14 10.35 37.94 % Of Sales - 5.47% 5.34% 5.38% 4.96% 2.89% 3.61% 2.86% 2.61% 2.32% 6.20% General & Admin Exp. - 22.45 20.68 12.48 15.32 14.93 8.05 8.69 8.45 9.00 10.51 % Of Sales - 2.87% 2.92% 2.39% 2.95% 2.65% 1.95% 1.87% 1.82% 2.02% 1.72% Selling & Distn. Exp. - 13.75 4.73 3.82 3.42 5.09 3.70 2.25 4.81 9.67 15.99 % Of Sales - 1.76% 0.67% 0.73% 0.66% 0.90% 0.90% 0.48% 1.03% 2.17% 2.61% Miscellaneous Exp. - 1.17 1.07 1.27 1.67 1.25 0.58 0.49 0.91 0.33 15.99 % Of Sales - 0.15% 0.15% 0.24% 0.32% 0.22% 0.14% 0.11% 0.20% 0.07% 0.13% EBITDA 161.89 139.98 116.98 54.73 114.77 121.14 80.03 90.14 93.34 75.14 89.21 EBITDA Margin 18.82% 17.88% 16.49% 10.48% 22.08% 21.51% 19.43% 19.39% 20.08% 16.87% 14.59% Other Income 5.57 6.22 4.46 4.91 5.20 3.45 5.11 3.40 2.39 1.45 3.61 Interest 20.84 18.54 23.60 21.97 19.16 11.19 12.32 11.92 15.48 15.82 17.11 Depreciation 37.11 34.34 31.52 32.13 32.15 22.28 22.07 19.27 19.90 19.18 19.43 PBT 109.51 93.32 66.33 5.55 68.65 91.12 50.76 62.35 60.35 41.58 56.27 Tax 28.36 24.94 16.91 1.47 0.62 30.16 18.07 20.90 19.89 5.97 14.63 Tax Rate 25.90% 26.73% 25.49% 26.49% 0.90% 33.10% 35.60% 33.52% 32.96% 14.36% 26.00% PAT 81.14 68.38 49.42 4.08 68.04 60.96 32.69 41.45 40.45 35.61 41.64 PAT before Minority Interest 81.14 68.38 49.42 4.08 68.04 60.96 32.69 41.45 40.45 35.61 41.64 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.43% 8.74% 6.97% 0.78% 13.09% 10.82% 7.94% 8.92% 8.70% 7.99% 6.81% PAT Growth 38.28% 38.37% 1,111.27% -94.00% 11.61% 86.48% -21.13% 2.47% 13.59% -14.48% EPS 8.66 7.30 5.27 0.44 7.26 6.51 3.49 4.42 4.32 3.80 4.44

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 860.03 782.75 709.26 522.05 519.87 563.18 411.95 464.91 464.93 445.49 611.53 Net Sales Growth 11.91% 10.36% 35.86% 0.42% -7.69% 36.71% -11.39% 0.00% 4.36% -27.15% Cost Of Goods Sold 484.20 437.06 424.26 335.80 275.45 340.00 246.36 292.71 289.90 295.85 385.15 Gross Profit 375.83 345.69 285.00 186.24 244.43 223.18 165.59 172.20 175.03 149.64 226.38 GP Margin 43.70% 44.16% 40.18% 35.67% 47.02% 39.63% 40.20% 37.04% 37.65% 33.59% 37.02% Total Expenditure 698.27 643.76 592.50 467.52 405.26 442.04 331.92 374.77 371.59 370.35 522.32 Power & Fuel Cost - 56.76 47.12 35.97 32.58 23.31 18.99 21.75 22.57 18.23 33.81 % Of Sales - 7.25% 6.64% 6.89% 6.27% 4.14% 4.61% 4.68% 4.85% 4.09% 5.53% Employee Cost - 69.72 56.78 50.08 51.02 41.17 39.35 35.59 32.80 26.92 38.11 % Of Sales - 8.91% 8.01% 9.59% 9.81% 7.31% 9.55% 7.66% 7.05% 6.04% 6.23% Manufacturing Exp. - 42.85 37.87 28.08 25.80 16.28 14.89 13.29 12.14 10.35 37.94 % Of Sales - 5.47% 5.34% 5.38% 4.96% 2.89% 3.61% 2.86% 2.61% 2.32% 6.20% General & Admin Exp. - 22.46 20.68 12.48 15.32 14.93 8.05 8.69 8.45 9.00 10.51 % Of Sales - 2.87% 2.92% 2.39% 2.95% 2.65% 1.95% 1.87% 1.82% 2.02% 1.72% Selling & Distn. Exp. - 13.75 4.73 3.82 3.42 5.09 3.70 2.25 4.81 9.67 15.99 % Of Sales - 1.76% 0.67% 0.73% 0.66% 0.90% 0.90% 0.48% 1.03% 2.17% 2.61% Miscellaneous Exp. - 1.17 1.07 1.27 1.67 1.25 0.58 0.49 0.91 0.33 15.99 % Of Sales - 0.15% 0.15% 0.24% 0.32% 0.22% 0.14% 0.11% 0.20% 0.07% 0.13% EBITDA 161.76 138.99 116.76 54.53 114.61 121.14 80.03 90.14 93.34 75.14 89.21 EBITDA Margin 18.81% 17.76% 16.46% 10.45% 22.05% 21.51% 19.43% 19.39% 20.08% 16.87% 14.59% Other Income 5.57 6.22 4.46 4.91 5.20 3.45 5.11 3.40 2.39 1.45 3.61 Interest 20.84 18.54 23.60 21.97 19.16 11.19 12.32 11.92 15.48 15.82 17.11 Depreciation 37.11 34.34 31.52 32.13 32.15 22.28 22.07 19.27 19.90 19.18 19.43 PBT 109.37 92.34 66.11 5.35 68.50 91.12 50.76 62.35 60.35 41.58 56.27 Tax 28.36 24.94 16.91 1.47 0.62 30.16 18.07 20.90 19.89 5.97 14.63 Tax Rate 25.93% 27.01% 25.58% 27.48% 0.91% 33.10% 35.60% 33.52% 32.96% 14.36% 26.00% PAT 81.00 67.40 49.20 3.88 67.88 60.96 32.69 41.45 40.45 35.61 41.64 PAT before Minority Interest 81.00 67.40 49.20 3.88 67.88 60.96 32.69 41.45 40.45 35.61 41.64 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.42% 8.61% 6.94% 0.74% 13.06% 10.82% 7.94% 8.92% 8.70% 7.99% 6.81% PAT Growth 38.30% 36.99% 1,168.04% -94.28% 11.35% 86.48% -21.13% 2.47% 13.59% -14.48% EPS 8.64 7.19 5.25 0.41 7.24 6.51 3.49 4.42 4.32 3.80 4.44

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 673.07 570.49 495.10 493.76 428.22 367.42 339.92 301.11 262.63 294.36 Share Capital 8.87 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 Total Reserves 648.33 533.45 486.63 485.30 419.76 358.96 331.46 292.64 254.17 285.90 Non-Current Liabilities 188.67 166.05 164.17 192.73 206.26 114.47 94.35 96.58 91.41 161.56 Secured Loans 138.16 120.89 119.93 148.30 146.21 67.02 61.01 70.20 73.02 109.58 Unsecured Loans 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 3.64 Long Term Provisions 1.21 1.16 1.40 1.57 1.84 1.73 1.52 2.18 1.35 3.43 Current Liabilities 344.50 346.72 254.97 211.48 211.43 154.21 156.05 134.29 156.00 200.43 Trade Payables 113.91 151.32 107.43 72.86 65.44 44.49 47.70 39.27 66.75 84.40 Other Current Liabilities 84.54 65.37 52.65 54.69 58.31 38.84 23.32 22.91 19.95 40.37 Short Term Borrowings 124.80 114.00 93.79 67.91 70.86 61.16 70.81 58.40 59.76 72.75 Short Term Provisions 21.24 16.03 1.10 16.02 16.82 9.72 14.22 13.71 9.54 2.90 Total Liabilities 1,206.24 1,083.26 914.24 897.97 845.91 636.10 590.32 531.98 510.04 656.35 Net Block 532.98 437.26 412.02 437.99 457.36 280.49 281.26 279.26 290.45 370.35 Gross Block 760.33 630.61 575.55 569.62 558.80 360.77 339.57 318.34 309.63 433.08 Accumulated Depreciation 227.35 193.35 163.53 131.63 101.44 80.29 58.31 39.08 19.18 62.73 Non Current Assets 631.64 534.36 503.54 505.92 520.58 408.32 369.23 350.66 343.68 408.79 Capital Work in Progress 34.67 30.27 33.19 11.00 6.74 42.12 18.30 8.20 7.76 12.80 Non Current Investment 45.11 45.10 45.10 45.00 45.00 45.00 45.00 45.00 36.98 21.27 Long Term Loans & Adv. 15.94 19.04 10.70 9.32 9.10 38.47 22.55 16.19 6.58 4.37 Other Non Current Assets 2.95 2.69 2.54 2.61 2.38 2.25 2.13 2.01 1.90 0.00 Current Assets 574.60 548.89 410.70 392.05 325.33 227.78 221.09 181.32 166.36 247.55 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 284.73 233.70 223.50 251.10 137.79 129.20 136.40 107.48 92.52 112.68 Sundry Debtors 203.23 236.23 148.35 48.52 105.68 48.77 26.02 24.15 21.32 61.09 Cash & Bank 41.58 36.20 7.47 46.66 40.51 9.65 14.88 12.71 12.37 15.08 Other Current Assets 45.05 6.77 6.00 6.39 41.35 40.16 43.79 36.98 40.15 58.70 Short Term Loans & Adv. 36.61 35.99 25.39 39.39 22.17 19.20 17.06 14.89 11.67 23.49 Net Current Assets 230.10 202.18 155.74 180.57 113.90 73.57 65.04 47.03 10.36 47.13 Total Assets 1,206.24 1,083.25 914.24 897.97 845.91 636.10 590.32 531.98 510.04 656.34

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 639.64 536.33 460.53 470.29 410.53 348.24 321.92 284.49 254.74 293.60 Share Capital 8.87 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 Total Reserves 614.90 499.29 452.06 461.82 402.06 339.77 313.45 276.02 246.28 285.14 Non-Current Liabilities 188.67 166.05 164.17 192.73 206.26 114.47 94.35 96.58 91.41 161.56 Secured Loans 138.16 120.89 119.93 148.30 146.21 67.02 61.01 70.20 73.02 109.58 Unsecured Loans 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 3.64 Long Term Provisions 1.21 1.16 1.40 1.57 1.84 1.73 1.52 2.18 1.35 3.43 Current Liabilities 344.50 346.72 254.97 211.48 211.43 154.21 156.05 134.29 156.00 200.43 Trade Payables 113.92 151.32 107.43 72.86 65.44 44.49 47.70 39.27 66.75 84.40 Other Current Liabilities 84.54 65.37 52.65 54.69 58.31 38.84 23.32 22.91 19.95 40.37 Short Term Borrowings 124.80 114.00 93.79 67.91 70.86 61.16 70.81 58.40 59.76 72.75 Short Term Provisions 21.24 16.03 1.10 16.02 16.82 9.72 14.22 13.71 9.54 2.90 Total Liabilities 1,172.81 1,049.10 879.67 874.50 828.22 616.92 572.32 515.36 502.15 655.59 Net Block 532.98 437.26 412.02 437.99 457.36 280.49 281.26 279.26 290.45 370.35 Gross Block 760.33 630.61 575.55 569.62 558.80 360.77 339.57 318.34 309.63 500.81 Accumulated Depreciation 227.35 193.35 163.53 131.63 101.44 80.29 58.31 39.08 19.18 130.46 Non Current Assets 598.21 500.20 468.96 482.45 502.88 389.13 351.22 334.04 335.80 408.04 Capital Work in Progress 34.67 30.27 33.19 11.00 6.74 42.12 18.30 8.20 7.76 12.80 Non Current Investment 11.68 10.94 10.52 21.53 27.30 25.81 26.99 28.38 29.10 20.51 Long Term Loans & Adv. 15.94 19.04 10.70 9.32 9.10 38.47 22.55 16.19 6.58 4.37 Other Non Current Assets 2.95 2.69 2.54 2.61 2.38 2.25 2.13 2.01 1.90 0.00 Current Assets 574.60 548.89 410.70 392.05 325.33 227.78 221.09 181.32 166.36 247.55 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 284.73 233.70 223.50 251.10 137.79 129.20 136.40 107.48 92.52 112.68 Sundry Debtors 203.23 236.23 148.35 48.52 105.68 48.77 26.02 24.15 21.32 61.09 Cash & Bank 41.59 36.20 7.47 46.66 40.51 9.65 14.88 12.71 12.37 15.08 Other Current Assets 45.05 6.77 6.00 6.39 41.35 40.16 43.79 36.98 40.15 58.70 Short Term Loans & Adv. 36.61 35.99 25.39 39.39 22.17 19.20 17.06 14.89 11.67 23.49 Net Current Assets 230.10 202.18 155.74 180.57 113.90 73.57 65.04 47.03 10.36 47.13 Total Assets 1,172.81 1,049.09 879.66 874.50 828.21 616.91 572.31 515.36 502.16 655.59

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 81.71 50.12 22.45 45.06 90.45 39.71 49.76 31.81 73.47 61.22 PBT 93.32 66.33 5.55 68.65 91.12 50.76 62.35 60.35 41.58 56.27 Adjustment 51.31 53.74 52.79 49.70 27.76 28.66 26.81 31.08 31.58 28.14 Changes in Working Capital -43.08 -54.55 -31.29 -58.38 -12.38 -27.60 -26.02 -48.48 9.40 -1.17 Cash after chg. in Working capital 101.55 65.52 27.05 59.98 106.50 51.82 63.14 42.95 82.56 83.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -19.83 -15.40 -4.60 -14.92 -16.05 -12.10 -13.38 -11.14 -9.09 -22.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -123.44 -52.07 -29.76 -27.15 -151.59 -42.56 -34.67 -16.58 -38.96 -96.72 Net Fixed Assets -134.12 -52.14 -28.12 -15.08 -162.65 -45.02 -31.33 -9.15 128.49 -28.01 Net Investments -0.01 0.00 -0.10 0.00 0.00 0.00 0.00 -8.02 -15.71 -8.04 Others 10.69 0.07 -1.54 -12.07 11.06 2.46 -3.34 0.59 -151.74 -60.67 Cash from Financing Activity 47.08 30.68 -31.97 -11.75 92.02 -2.40 -12.92 -14.89 -33.19 44.34 Net Cash Inflow / Outflow 5.35 28.73 -39.27 6.16 30.88 -5.25 2.17 0.35 1.32 8.84 Opening Cash & Equivalents 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25 2.41 Closing Cash & Equivalent 41.39 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 81.71 50.12 22.45 45.06 90.45 39.71 49.76 31.81 73.47 61.22 PBT 92.34 66.11 5.35 68.50 91.12 50.76 62.35 60.35 41.58 56.27 Adjustment 52.28 53.97 52.99 49.86 27.76 28.66 26.81 31.08 31.58 28.14 Changes in Working Capital -43.08 -54.55 -31.29 -58.38 -12.38 -27.60 -26.02 -48.48 9.40 -1.17 Cash after chg. in Working capital 101.54 65.52 27.05 59.98 106.50 51.82 63.14 42.95 82.56 83.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -19.83 -15.40 -4.60 -14.92 -16.05 -12.10 -13.38 -11.14 -9.09 -22.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -123.43 -52.07 -29.76 -27.15 -151.59 -42.56 -34.67 -16.58 -38.96 -96.72 Net Fixed Assets -134.12 -52.14 -28.12 -15.08 -162.65 -45.02 -31.33 -9.15 128.49 -346.44 Net Investments -0.01 0.00 -0.10 0.00 0.00 0.00 0.00 -8.02 -15.71 -17.94 Others 10.70 0.07 -1.54 -12.07 11.06 2.46 -3.34 0.59 -151.74 267.66 Cash from Financing Activity 47.08 30.68 -31.97 -11.75 92.02 -2.40 -12.92 -14.89 -33.19 44.34 Net Cash Inflow / Outflow 5.36 28.73 -39.27 6.16 30.88 -5.25 2.17 0.35 1.32 8.84 Opening Cash & Equivalents 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25 2.41 Closing Cash & Equivalent 41.40 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 74.13 64.02 58.49 58.33 50.59 43.40 40.16 35.57 31.02 34.77 ROA 5.97% 4.95% 0.45% 7.80% 8.23% 5.33% 7.39% 7.76% 6.11% 6.96% ROE 11.41% 9.53% 0.83% 14.76% 15.32% 9.24% 12.93% 14.35% 12.79% 15.17% ROCE 12.20% 11.25% 3.67% 12.26% 17.07% 12.57% 15.96% 17.66% 12.61% 15.95% Fixed Asset Turnover 1.22 1.27 0.97 0.98 1.32 1.29 1.53 1.59 1.22 1.53 Receivable days 94.73 91.77 65.01 50.80 46.40 30.27 18.23 16.66 33.12 34.86 Inventory Days 111.76 109.10 156.71 128.12 80.21 107.49 88.61 73.28 82.47 57.59 Payable days 111.00 111.36 98.04 91.68 59.01 46.62 40.24 46.81 71.90 49.65 Cash Conversion Cycle 95.49 89.51 123.68 87.24 67.61 91.14 66.60 43.12 43.69 42.80 Total Debt/Equity 0.47 0.52 0.51 0.53 0.59 0.41 0.42 0.49 0.57 0.69 Interest Cover 6.03 3.81 1.25 4.58 9.14 5.12 6.23 4.90 3.63 4.29

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 70.36 59.98 54.40 55.56 48.50 41.14 38.03 33.61 30.09 34.68 ROA 6.07% 5.10% 0.44% 7.97% 8.44% 5.50% 7.62% 7.95% 6.15% 8.46% ROE 11.91% 10.16% 0.83% 15.41% 16.07% 9.76% 13.67% 15.00% 12.99% 17.57% ROCE 12.55% 11.73% 3.79% 12.60% 17.62% 13.06% 16.57% 18.17% 12.73% 19.54% Fixed Asset Turnover 1.22 1.27 0.97 0.98 1.32 1.29 1.53 1.59 1.12 2.11 Receivable days 94.73 91.77 65.01 50.80 46.40 30.27 18.23 16.66 33.12 35.09 Inventory Days 111.76 109.10 156.71 128.12 80.21 107.49 88.61 73.28 82.47 47.02 Payable days 110.75 111.30 97.98 91.63 59.01 46.62 40.24 46.81 71.90 36.96 Cash Conversion Cycle 95.74 89.57 123.74 87.30 67.61 91.14 66.60 43.12 43.69 45.14 Total Debt/Equity 0.50 0.55 0.55 0.55 0.61 0.44 0.45 0.51 0.59 0.70 Interest Cover 5.98 3.80 1.24 4.57 9.14 5.12 6.23 4.90 3.63 4.29

Top Investors:

quant mutual fund - quant small cap fund

venkata subbaraju penmatsa (huf)

sudeepthi gopineedi

venkata praveen talluri

vivek mundra

aniruddh mundra

Annual Reports:

News Update:

SMS Pharmaceuticals - Quarterly Results
9th Nov 2025, 00:00 AM

Read More
SMS Pharmaceuticals gets EIR for Central Laboratory Analytical Services
28th Aug 2025, 12:50 PM

The company has received the EIR with ‘No Action Indicated’ status
Read More

SMS Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

BSE: 532815 | NSE: SMSPHARMA

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

SMS Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

BSE: 532815 | NSE: SMSPHARMA

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: